Search

Your search keyword '"Karakurt, Sait"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Karakurt, Sait" Remove constraint Author: "Karakurt, Sait"
350 results on '"Karakurt, Sait"'

Search Results

4. Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19

5. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

6. Evaluation of the Effect of Management of Drug-Related Problems on Clinical Outcomes of Pulmonary Embolism Outpatients: A Randomized Controlled Trial.

7. Challenges in Non-Invasive Ventilation: Understanding the Causes of NIV Failure and Complications.

10. A Rare Geriatric Case: Omalizumab As a Rescue Therapy For Asthma-Chronic Obstructive Pulmonary Disease Overlap.

11. The Role of the Respiratory Rate Oxygenation (ROX) Index in the Early Identification of High-Risk Severe Acute Respiratory Infection (SARI) Patients Caused by COVID-19.

13. Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission.

17. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE)

20. CLINICAL PHARMACIST-LED MEDICATION REVIEW IN HOSPITALIZED CONFIRMED OR PROBABLE PATIENTS WITH COVID-19 DURING THE FIRST WAVE OF COVID-19 PANDEMIC

22. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic.

25. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

34. Spontaneous pneumothorax and ozone levels: is there a relation?

35. Noninvasive positive pressure ventilation in unplanned extubation

36. TÜTÜN KONTROLÜNDE GÜNCEL TEHDITLER

37. Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.

38. Pharmacokinetic characterization of favipiravir in patients with COVID‐19

47. Evaluation of Consultations Requested from Emergency Departments to Chest Diseases Department

49. Pharmacokinetic characterization of favipiravir in patients with COVID-19 and patient outcome

50. Impact of concomitant obstructive sleep apnea on pulmonary involvement and main pulmonary artery diameter in adults with scleroderma

Catalog

Books, media, physical & digital resources